Paclitaxel is metabolized by cytochrome P450 (CYP) in the liver [14]; thus chemotherapy using paclitaxel requires less hydration, and renal failure occurs less frequently than with CDDP use. The gene discussed is PPIG; the disease is acute kidney injury.